Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
NCT00485368
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
17
Enrollment
OTHER_GOV
Sponsor class
Conditions
Marfan Syndrome
Interventions
DRUG:
Coversyl (perindopril)
Sponsor
Bayside Health
Collaborators
[object Object]
[object Object]